Activo® Liquid - in vitro Trial Results
Is it possible to inhibit growth of antibiotic resistant pathogens (ESBL, MRSA) by the use of Activo® Liquid in vitro?
In this trial four ESBL producing E. coli, two MRSA and the nonresistant reference strains all isolated from farms were tested concerning their sensitivity against Activo® Liquid. Every bacteria strain (Concentration:1x104 Cfu/ml) had to undergo a bacterial inhibition assay in the appropriate medium at 37°C for 6-7 hours. (Laboratory: Vaxxinova, Münster)